Fierce Pharma

APRIL 18, 2024

Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year.

337

337

Pharmaceutical Technology

APRIL 18, 2024

Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.

129

129

Fierce Pharma

APRIL 18, 2024

During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. | During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. A spokesperson said the company would offer affected employees a chance to apply for new roles, plus "outplacement services.

302

302

MedCity News

APRIL 18, 2024

Achieving strong cybersecurity is a vast, interconnected web that must incorporate the correct software, procedures, and workflows and take into account the human element across an entire organization. The post In the World of Interoperability, How to Meaningfully Strengthen Cybersecurity appeared first on MedCity News.

118

118

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 18, 2024

Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics. | Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company's acquisition of Horizon Therapeutics.

284

284

MedCity News

APRIL 18, 2024

Cerevel Therapeutics drug tavapadon met the main and secondary goals of a pivotal Parkinson’s disease clinical trial. That drug and others will join the neuroscience portfolio of AbbVie, which is in the process of acquiring Cerevel. The post Novel Parkinson’s Disease Drug Will Join AbbVie With Positive Phase 3 Data In Hand appeared first on MedCity News.

Biopharma 111

Biopharma Pharma 111

European Pharmaceutical Review

APRIL 18, 2024

New trial results for GSK’s oral gepotidacin, a potential first-in-class oral antibiotic, has shown that it was non-inferior with 92.6 percent success rates in patients with uncomplicated urogenital gonorrhoea (GC). “These results highlight the potential of gepotidacin as a new oral treatment option given the rising incidence of gonorrhoea worldwide” In the pivotal EAGLE-1 Phase III trial, comparatively, intramuscular ceftriaxone (500mg) plus oral azithromycin (1,000mg) combined therapy, a

Leads 105

Leads Safety Patients Pharmaceutical 105

Fierce Pharma

APRIL 18, 2024

Two weeks after gaining a hard-earned FDA label expansion for its long-established antipsychotic drug Fanapt (iloperidone), Vanda Pharmaceuticals has derailed a hostile takeover bid. | Two weeks after gaining a hard-earned FDA label expansion for its long-established antipsychotic drug Fanapt (iloperidone), Vanda Pharmaceuticals has rejected a hostile takeover bid.

FDA 243

FDA Pharmaceutical 243

pharmaphorum

APRIL 18, 2024

UK researchers describe an algorithm that is more accurate than current tools at predicting an individual’s risk of developing cardiovascular disease in the next 10 years.

107

107

Fierce Pharma

APRIL 18, 2024

Less than a year ago, AbbVie's star immunology drug Rinvoq picked up its seventh FDA approval< | AbbVie's Rinvoq has racked up seven FDA approvals in recent years, and another expansion into giant cell arteritis could be in the cards after a positive trial.

FDA 242

FDA 242

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

APRIL 18, 2024

Q1 2024 saw a significant rise in the number of hospital M&A deals compared to the past three Q1s. Experts believe this M&A activity will continue to climb throughout this year and next — motivated by both financial distress and hospitals’ desire to improve strategic business lines like value-based care and digital healthcare services. The post Hospital M&A Activity in 2024: What to Expect appeared first on MedCity News.

Healthcare 109

Healthcare Healthcare 109

Fierce Pharma

APRIL 18, 2024

After striking out in an attempt to create a niche for its COVID-19 vaccine, Valneva is taking its swings at what it does best—developing, manufacturing and commercializing vaccines for a variety o | After striking out in an attempt to create a niche for its COVID-19 vaccine, Valneva is back to doing what it does best—developing, manufacturing and commercializing vaccines for a variety of infectious diseases with unmet needs.

Manufacturing 144

Manufacturing 144

MedCity News

APRIL 18, 2024

Included Health’s new specialty care clinic, which will become available in 2025, is starting by offering three centers: the Cancer Center, the Center for Women’s Health and the Center for Metabolic Health. The post Included Health Announces New Specialty Care Offering appeared first on MedCity News.

109

109

Pharmaceutical Technology

APRIL 18, 2024

Inflammation, cell metabolism and neuronal health are current key areas of focus for dementia researchers, according to Jane Osbourn, chief scientific officer (CSO) at Alchemab.

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

LEVO Health

APRIL 18, 2024

At Levo Health, we’re always on the lookout for opportunities to push the boundaries of healthcare marketing and support innovations that can transform the industry. This year, we’re thrilled to take our commitment a step further by sponsoring the 2024 HealthTech|X Accelerator program hosted by Tampa Bay Wave. Tampa Bay Wave has a proven track record of fostering startup success, having supported 527 startups, collectively raising over $900 million in capital and creating more than 5

Healthcare 98

Healthcare Healthcare Competition Training 98

Copyright Clearance Center

APRIL 18, 2024

In a recent town hall webinar, The Heart of the Matter: Copy­right, AI Training and LLMs, CCC (Copyright Clearance Center) made the case that current artificial intelligence (AI) technology infringes copyrights, both in the way its underlying large language models (LLMs) are developed, or trained, and in the outputs it enables users to create.

Training 98

Training 98

European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). While pharmaceutical manufacturing’s overall contribution is small compared to patient use and inappropriate disposal of pharmaceuticals, inadequately managed manufacturing emissions can impact local environments and receiving waters.

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

MedCity News

APRIL 18, 2024

Major malpractice verdicts have spiked in recent years. The post Healthcare Docket: Help Wanted — Doctor Expert Witnesses appeared first on MedCity News.

Doctors 110

Doctors Healthcare Healthcare Medical 110

Advertisement

pharmaphorum

APRIL 18, 2024

New obesity biotech Metsera formally launches, led by Clive Meanwell and with a $290m warchest to take on the likes of Novo Nordisk and Eli Lilly.

103

103

MedCity News

APRIL 18, 2024

A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different vision? The post 23andMe: What If … appeared first on MedCity News.

Biopharma 101

Biopharma 101

pharmaphorum

APRIL 18, 2024

Ireland makes the case for its role as Europe's medtech hotspot, helping companies tackle emerging challenges like digitalisation and sustainability.

100

100

Pharmaceutical Technology

APRIL 18, 2024

Clearmind Medicine has entered into a licensing agreement with Yissum to develop Generation 3.0 psychedelic compounds for mental disorders.

Medicine 98

Medicine 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

APRIL 18, 2024

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA.

FDA 109

FDA 109

Pharmaceutical Commerce

APRIL 18, 2024

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

105

105

PharmaTimes

APRIL 18, 2024

The Tyche model could help clinicians and researchers capture crucial information in images

Medical 102

Medical 102

MedCity News

APRIL 18, 2024

Medicare’s Chronic Care Management program reduced emergency room and in-patient hospital visits and lowered total health spending, but uptake has been sluggish for a variety of reasons. The post Medicare’s Push To Improve Chronic Care Attracts Businesses, but Not Many Doctors appeared first on MedCity News.

Doctors 66

Doctors Management Patients Physicians 66

Advertisement

Distribution

Pharmaceutical Commerce

APRIL 18, 2024

The latest news for pharma industry insiders.

Ethics 105

Ethics Pharma 105

PharmExec

APRIL 18, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics, provides an update on the progress of Coya 302 as a treatment for ALS.

52

52

Clarify Health

APRIL 18, 2024

As both government and commercial payers direct a greater share of volume to out-patient facilities and patient demand for same-day service increases, opportunity and competition in the ambulatory surgical center (ASC) space are increasing. The U.S. ASC market size is projected to grow to more than $75 billion by 2030 and in January 2024, CMS announced the addition of 41 new billing codes for covered procedures for ASCs.

Marketing 52

Marketing Competition Physicians Management 52

PharmaTech

APRIL 18, 2024

Polyimide materials, as Kapton®, are widely used for flexible electronics substrates or as insulators, thanks to their wide range of thermal stability as well as excellent dielectric and mechanical properties. However, there are limitations in their processability and employment in new technologies due to their low solubility and deep amber staining, resulting from charge transfer interactions, established between polymer rigid chains.

Electronics 52

Electronics Specialization 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales